Prelude Therapeutics Incorporated Common Stock — Institutional Ownership
Which tracked institutions hold PRLD, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
12
Funds holding
$3949848
Total value held
Buying
8 added/new · 2 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | $1101790 | 322161 | -12755 | -3.81% |
| 2 | Blackrock, Inc. | $1100850 | 321886 | +55606 | +20.88% |
| 3 | Goldman Sachs Group Inc | $808724 | 236469 | +118992 | +101.29% |
| 4 | State Street Corp | $472750 | 138231 | +10939 | +8.59% |
| 5 | Bank Of America Corp /De/ | $193316 | 56525 | +46717 | +476.32% |
| 6 | Northern Trust Corp | $171410 | 50120 | — | Held |
| 7 | Prudential Financial Inc | $59576 | 17420 | +1900 | +12.24% |
| 8 | Barclays Plc | $29412 | 8600 | — | NEW BUY |
| 9 | Royal Bank Of Canada | $8000 | 2331 | — | NEW BUY |
| 10 | Pnc Financial Services Group, Inc. | $4005 | 1171 | — | Held |
| 11 | Amalgamated Financial Corp. | $12 | 1764 | — | NEW BUY |
| 12 | Citigroup Inc | $3 | 1 | -5974 | -99.98% |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.